1. Home
  2. INGN vs KRRO Comparison

INGN vs KRRO Comparison

Compare INGN & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

N/A

Current Price

$5.56

Market Cap

177.1M

Sector

Health Care

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

N/A

Current Price

$13.53

Market Cap

187.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INGN
KRRO
Founded
2001
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.1M
187.9M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
INGN
KRRO
Price
$5.56
$13.53
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$11.25
$34.80
AVG Volume (30 Days)
230.4K
92.3K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
N/A
EPS
N/A
N/A
Revenue
$348,668,000.00
$6,392,000.00
Revenue This Year
$8.03
N/A
Revenue Next Year
$7.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
181.46
52 Week Low
$5.34
$5.20
52 Week High
$9.13
$55.89

Technical Indicators

Market Signals
Indicator
INGN
KRRO
Relative Strength Index (RSI) 33.31 59.88
Support Level $5.48 $9.76
Resistance Level $6.73 $14.45
Average True Range (ATR) 0.20 0.78
MACD -0.04 0.09
Stochastic Oscillator 6.48 82.71

Price Performance

Historical Comparison
INGN
KRRO

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: